Transdermal menopausal hormone therapy: delivery through skin changes the rules

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Expert Opinion on Pharmacotherapy

• Publication date

  2010-05-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14656561003774098PMID 20426703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Study of adverse outcomes in women using testosterone therapy.

  2009influential reference
• Menopausal hot flushes revisited

  2009cited by this paper
• Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition.

  2009cited by this paper
• Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study.

  2009cited by this paper
• Effect of hormone replacement therapy on inflammatory biomarkers.

  2009cited by this paper
• Androgens, estrogens, and metabolic syndrome at midlife.

  2009influential reference
• Safety of testosterone use in women.

  2009influential reference
• Low-Dose Estradiol Spray: a Novel Treatment for Vasomotor Instability in Postmenopausal Women

  2009cited by this paper
• Testosterone for low libido in postmenopausal women not taking estrogen.

  2008influential reference
• The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.

  2008influential reference
• Testosterone therapy for sexual dysfunction in postmenopausal women

  2008influential reference
• Hormone therapy and risk of myocardial infarction: a national register study.

  2008cited by this paper
• Low-Dose Estradiol Spray to Treat Vasomotor Symptoms: A Randomized Controlled Trial

  2008influential reference
• The menopausal hot flush--anything new?

  2008cited by this paper
• Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure

  2008cited by this paper
• A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women.

  2008influential reference
• Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality.

  2008cited by this paper
• Menopause -what's new?

  2008cited by this paper
• Testosterone and the breast

  2008influential reference
• Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.

  2008cited by this paper
• Erratum: Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: Results from the INTIMATE NM1 Study (Menopause (2006) 13, (770-779))

  2007cited by this paper
• Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study

  2007cited by this paper
• A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women

  2007influential reference
• Low Dose of Transdermal Estradiol Gel for Treatment of Symptomatic Postmenopausal Women: A Randomized Controlled Trial

  2007cited by this paper
• Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society

  2007cited by this paper
• Female sexual dysfunction in hypopituitarism.

  2007cited by this paper
• Are the Endocrine Society's Clinical Practice Guidelines on Androgen Therapy in Women misguided? A commentary.

  2007cited by this paper
• The Endocrine Society Clinical Practice Guideline and The North American Menopause Society position statement on androgen therapy in women: another one of Yogi's forks.

  2007influential reference
• Treatment with percutanous testosterone gel in postmenopausal women with decreased libido--effects on sexuality and psychological general well-being.

  2006cited by this paper
• Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study

  2006influential reference
• Effects of intranasal 17&bgr;-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women

  2006cited by this paper
• A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.

  2006cited by this paper
• Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.

  2006cited by this paper
• Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment.

  2006cited by this paper
• Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study

  2006cited by this paper
• Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial

  2006influential reference
• Hypoactive sexual desire disorder in menopausal women: a survey of Western European women.

  2006cited by this paper
• Androgen therapy in women: an Endocrine Society Clinical Practice guideline.

  2006cited by this paper
• Men, women, and testosterone: Why did the FDA fail Intrinsa?

  2005cited by this paper
• Prothrombotic Mutations, Hormone Therapy, and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration

  2005cited by this paper
• Testosterone Patch for Low Sexual Desire in Surgically Menopausal Women: A Randomized Trial

  2005cited by this paper
• Safety and Efficacy of a Testosterone Patch for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women: A Randomized, Placebo-Controlled Trial

  2005cited by this paper
• Menopausal vasomotor symptoms: a review of causes, effects and evidence-based treatment options.

  2005cited by this paper
• Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.

  2005influential reference
• Is dehydroepiandrosterone a hormone?

  2005influential reference
• Goldilocks and menopause.

  2005cited by this paper
• Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.

  2005influential reference
• Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy

  2004cited by this paper
• Estrogen and progestogen use in peri- and postmenopausal women: September 2003 position statement of The North American Menopause Society.

  2003cited by this paper
• Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

  2003cited by this paper
• Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.

  2003influential reference
• Hormones, mood, sexuality, and the menopausal transition.

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002influential reference
• Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.

  2001cited by this paper
• Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.

  2000influential reference
• Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management.

  2000cited by this paper
• Estradiol pharmacokinetics after transdermal application of patches to postmenopausal women: matrix versus reservoir patches

  2000cited by this paper
• Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.

  1999cited by this paper
• Which androgen replacement therapy for women?

  1998influential reference
• Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.

  1997cited by this paper
• The menopause and hormone replacement therapy: lipids, lipoproteins, coagulation and fibrinolytic factors.

  1996cited by this paper
• Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality.

  1995cited by this paper
• Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy.

  1995cited by this paper
• Pharmacokinetic and Pharmacologic Variation Between Different Estrogen Products

  1995influential reference
• Elective ovarian removal and estrogen replacement therapy--effects on sexual life, psychological well-being and androgen status.

  1993cited by this paper
• A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies. The Transdermal HRT Investigators Group.

  1993cited by this paper
• The role of androgen in the maintenance of sexual functioning in oophorectomized women.

  1987cited by this paper
• Biologic effects of transdermal estradiol

  1986influential reference
• Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause.

  1985cited by this paper
• A genetic component to the variation of dehydroepiandrosterone sulfate.

  1985cited by this paper
• Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood.

  1984cited by this paper
• Objective Techniques for the Assessment of Postmenopausal Hot Flashes

  1981influential reference
• Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle.

  1974cited by this paper
• Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer.

  1974cited by this paper
• Nams Continuing Medical Education Activity

  year unknowncited by this paper

• Менопаузальна гормональна терапія після епохи «чорних рамок»: роль трансдермальних естрогенів у зміні парадигми

  2026cites this paper
• Measurement of serum estradiol in the menopause transition

  2025cites this paper
• Novel Therapeutic Hybrid Systems Using Hydrogels and Nanotechnology: A Focus on Nanoemulgels for the Treatment of Skin Diseases

  2024cites this paper
• An emerging era in manufacturing of drug delivery systems: Nanofabrication techniques

  2023cites this paper
• Effects of menopausal hormone therapy on the risk of ovarian cancer: Health Insurance Database in South Korea–based cohort study

  2023cites this paper
• Changes in menopausal symptoms comparing oral estradiol versus transdermal estradiol

  2023cites this paper
• Oestrogen-based therapies for menopausal symptoms.

  2023cites this paper
• Development of Pharmaceutical Nanomedicines: From the Bench to the Market

  2022cites this paper
• Menopausal hormone therapy treatment options and ovarian cancer risk: A Swedish prospective population‐based matched‐cohort study

  2020influential citation
• Nanolipid-Trehalose Conjugates and Nano-Assemblies as Putative Autophagy Inducers

  2019cites this paper
• Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities.

  2019cites this paper
• Different menopausal hormone regimens and risk of breast cancer

  2018cites this paper
• Sexual and Reproductive Dysfunction in Young Female Cancer Patients

  2017cites this paper
• 13 Adrenal, Reproductive, and Thyroid Hormone Testing for Depression

  2016cites this paper
• Oral versus transdermal hormone therapy at menopause

  2015cites this paper
• NJK14013, a novel synthetic estrogen receptor-α agonist, exhibits estrogen receptor-independent, tumor cell-specific cytotoxicity.

  2015cites this paper
• Development and validation of in vitro-in vivo correlation (IVIVC) for estradiol transdermal drug delivery systems.

  2015cites this paper
• Effects of Hormone Replacement Therapy on Skin Viscoelasticity During Climacteric Aging

  2015cites this paper
• Managing female sexual dysfunction.

  2013cites this paper
• Pulsatile administration of testosterone by the vaginal route using Pentravan ®

  2013cites this paper
• Revisiting the Cutaneous Impact of Oral Hormone Replacement Therapy

  2013cites this paper
• Skin academy: hair, skin, hormones and menopause - current status/knowledge on the management of hair disorders in menopausal women.

  2012cites this paper
• A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women’s Health Initiative

  2012cites this paper
• A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement.

  2011cites this paper
• Role of androgens in modulating male and female sexual function

  2010cites this paper
• International Journal of General Medicine Dovepress Efficacy of Biorhythmic Transdermal Combined Hormone Treatment in Relieving Climacteric Symptoms: a Pilot Study

  year unknowncites this paper